Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) EBT Margin: 2012-2025

Historic EBT Margin for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to 14.32%.

  • Veracyte's EBT Margin fell 22.00% to 14.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.26%, marking a year-over-year increase of 818.00%. This contributed to the annual value of 5.78% for FY2024, which is 2699.00% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's EBT Margin is 14.32%, which was up 1,391.55% from 0.96% recorded in Q2 2025.
  • In the past 5 years, Veracyte's EBT Margin ranged from a high of 14.54% in Q3 2024 and a low of -124.41% during Q1 2021.
  • Over the past 3 years, Veracyte's median EBT Margin value was 0.96% (recorded in 2025), while the average stood at -3.58%.
  • Per our database at Business Quant, Veracyte's EBT Margin tumbled by 8,677bps in 2021 and then spiked by 10,307bps in 2022.
  • Over the past 5 years, Veracyte's EBT Margin (Quarterly) stood at -16.81% in 2021, then surged by 1,252bps to -4.29% in 2022, then plummeted by 2,675bps to -31.03% in 2023, then spiked by 3,393bps to 2.90% in 2024, then decreased by 22bps to 14.32% in 2025.
  • Its last three reported values are 14.32% in Q3 2025, 0.96% for Q2 2025, and 6.49% during Q1 2025.